CIK 0001077183
- Large accelerated filer
NEOGENOMICS INC
Sign in to watch- Ticker
- NEO
- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 742897368
- Phone
- +1 239-768-0600
- Business address
- 9490 NEOGENOMICS WAY, FORT MYERS, FL, 33912
- Former names
- AMERICAN COMMUNICATIONS ENTERPRISES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-02 | Stahler Rachel A Director | Grant or award · Stock Option (Right to Buy) | +3,714 | 3,714 | ||
| 2021-06-02 | TETRAULT LYNN A. Director | Grant or award | +3,081 | 33,550 | ||
| 2021-06-02 | TETRAULT LYNN A. Director | Grant or award · Stock Option (Right to Buy) | +3,714 | 3,714 | ||
| 2021-06-02 | CROWTHER BRUCE K Director | Grant or award | +3,081 | 49,564 | ||
| 2021-06-02 | CROWTHER BRUCE K Director | Grant or award · Stock Option (Right to Buy) | +3,714 | 3,714 | ||
| 2021-06-02 | KANOVSKY STEPHEN M Director | Grant or award | +3,081 | 9,198 | ||
| 2021-06-02 | KANOVSKY STEPHEN M Director | Grant or award · Stock Options (Right to Buy) | +3,714 | 3,714 | ||
| 2021-06-02 | CARDOZA GEORGE President, Pharma Services | Sale | −169,230 | $40.39 | $6.8M | 207,879 |
| 2021-05-25 | SHOVLIN ROBERT J. President, Clinical Services | Exercise or conversion | +96,167 | $8.03 | $772K | 249,914 |
| 2021-05-25 | SHOVLIN ROBERT J. President, Clinical Services | Exercise or conversion | +16,724 | $19.60 | $328K | 266,638 |
| 2021-05-25 | SHOVLIN ROBERT J. President, Clinical Services | Exercise or conversion | +14,067 | $28.33 | $399K | 280,705 |
| 2021-05-25 | SHOVLIN ROBERT J. President, Clinical Services | Sale | −130,604 | $39.31 | $5.1M | 150,101 |
| 2021-05-25 | SHOVLIN ROBERT J. President, Clinical Services | Exercise or conversion · Stock Option (Right to Buy) | −96,167 | 0 | ||
| 2021-05-25 | SHOVLIN ROBERT J. President, Clinical Services | Exercise or conversion · Stock Option (Right to Buy) | −16,724 | 33,449 | ||
| 2021-05-25 | SHOVLIN ROBERT J. President, Clinical Services | Exercise or conversion · Stock Option (Right to Buy) | −14,067 | 42,204 | ||
| 2021-04-22 | Weiss Lawrence Martin Chief Medical Officer | Exercise or conversion | +6,667 | $9.22 | $61K | 112,464 |
| 2021-04-22 | Weiss Lawrence Martin Chief Medical Officer | Exercise or conversion | +9,005 | $19.60 | $176K | 121,469 |
| 2021-04-22 | Weiss Lawrence Martin Chief Medical Officer | Exercise or conversion | +9,378 | $28.33 | $266K | 130,847 |
| 2021-04-22 | Weiss Lawrence Martin Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −6,667 | 0 | ||
| 2021-04-22 | Weiss Lawrence Martin Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −9,005 | 18,012 |
Page 25 of 51 · 1,005 trades